Lab News & Accomplishments

  • September 2023: Congrats to Adam for successfully defneding his PhD on "Insights into CD4+ T cell help in SARS-CoV-2 infection and malaria in pregnancy"!
  • September 2023: Congrats to Adam for his publication comparing cellular immune responses between primigravid and multigravid women in malaria-endemic regions and assessing the role of Tr1 cells as a correlate of protection against malaria in pregnancy.
  • June 2023: Congrats to Karen for completing her Fellowship in Infectious Diseases at Stanford.
  • May 2023: Congrats to Jason for being awarded the Stanford Graduate Interdisciplinary Fellowship.
  • May 2023: Congrats to Jordan for his Master's Thesis presentation on "Non-Malarial Fevers and Antimicrobial Use in a Cohort of Ugandan Pregnant Women Enrolled in a Malaria Chemoprevention Trial: A Causal Mediation Analysis."
  • January 2023: Congrats to Maureen for her publication profiling NK cell responses after repeated malaria exposure in Ugandan children.
  • October 2022: Congrats to Karen for being awarded the Burroughs Welcome Fund/ASTMH Postdoctoral Fellowship as well as receiving two ASTMH awards: ACCTMTH Clinical Research Award, 2nd place, and the Young Investigator Award, 1st tier mention!
  • August 2022: Congrats to Savannah for being awarded the McCoy Family Center for Ethics in Society Graduate Fellowship!
  • July 2022: Congrats to Jason on his oral presentation at the 2022 EMBL Innate immunity in host-pathogen interactions conference in July 2022!
  • May 2022:  Congrats to Kattria for her publication evaluating CD4 T cell dynamics following COVID-19 published in Cell Reports Medicine! 
  • May 2022: Congrats to Jason on receiving the 2022 ITI Pilot Project Award!
  • April 2022: Congrats to the Bhatt lab who used samples collected from the Lambda clinical trial to report that patients with mild to moderate COVID-19 can shed RNA in their stool up to 7 months post-infection! 
  • February 2022:  We enrolled our first participant into the Modifying immunity in children with DihydROartemisinin Piperaquine (MIC-DroP) trial! (NCT 04978272)
  • January 2022: Congrats to the Wang lab for their study utilizing samples collected from the Lambda clinical trial that implicate early, non-neutralizing afucosulated IgG antibodies in COVID-19 pathogenesis!
  • November 2021: Congrats to Nick on his publication in Clinical Infectious Diseases describing infant immune phenotypes of malaria and age-dependent sickle cell trait protection in Uganda children! 

In the Press

External News

Internal News

Follow us on Twitter!